ASMB Dividend: Assembly Biosciences Inc Yield Insights

ASMB Financial

Assembly Biosciences Inc

$35

2.97%

$1

At close: Dec 03, 16:00:00 GMT-5

$35

Pre-market: Dec 04, 06:31:04 GMT-5

Income

Balance sheet

Cash flow

Annual

Quarterly

ASMB Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	37	28	7	0	6	79
Revenue Growth (YoY)	32%	300%	--	-100%	-92%	426.99%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	18	18	22	23	28	36
Research & Development	61	55	48	69	70	101
Operating Expenses	80	73	71	93	98	138
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-38	-39	-61	-93	-132	-62
Income Tax Expense	0	0	0	0	-2	--
Net Income	-38	-40	-61	-93	-129	-62
Net Income Growth	-5%	-34%	-34%	-28%	108%	-36%
Shares Outstanding (Diluted)	12.68	6	4.57	4.03	3.6	2.95
Shares Change (YoY)	100%	31%	13%	12%	22%	35%
EPS (Diluted)	-3.03	-6.69	-13.38	-23.08	-36.01	-21.05
EPS Growth	-53%	-50%	-42%	-36%	71%	-53%
Free Cash Flow	-55	-51	22	-84	-96	-65
Free Cash Flow Per Share	-4.33	-8.49	4.8	-20.82	-26.61	-22.01
Gross Margin	--	--	--	--	--	--
Operating Margin	-116.21%	-160.71%	-914.28%	0%	-1,533.33%	-74.68%
Profit Margin	-102.7%	-142.85%	-871.42%	0%	-2,150%	-78.48%
Free Cash Flow Margin	-148.64%	-182.14%	314.28%	0%	-1,600%	-82.27%
EBITDA	-43	-45	-64	-93	-92	-59
EBITDA Margin	-116.21%	-160.71%	-914.28%	0%	-1,533.33%	-74.68%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-43	-45	-64	-93	-92	-59
EBIT Margin	-116.21%	-160.71%	-914.28%	0%	-1,533.33%	-74.68%
Effective Tax Rate	0%	0%	0%	0%	1.51%	--